首页>新闻资讯 2025-06-30 10:18:55
「同位素标记抑制剂」CAS:2748605-29-8|Brexpiprazole S-oxide-d8
生物活性:Brexpiprazole S-oxide-d8 is a deuterium labeled Brexpiprazole S-oxide. Brexpiprazole S-oxide is a main metabolite of Brexpiprazole and is metabolized by cytochrome P450 3A4 (CYP3A4). Brexpiprazole is an atypical antipsychotic agent and a partial agonist of human 5-HT1A and dopamine receptor with Kis of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also a 5-HT2A receptor antagonist with a Ki of 0.47 nM[1][2][3].
IC50 & Target[2]
5-HT1A Receptor
0.12 nM (Ki)
5-HT2A Receptor
0.47 nM (Ki)
D2 Receptor
0.3 nM (Ki)
分子量:457.61
Formula:C25H19D8N3O3S
CAS 号:2748605-29-8
非标记 CAS:1191900-51-2
性状:固体
颜色:White to off-white
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Powder:-20°C:3 years,4°C:2 years
In solvent:-80°C:6 months,-20°C:1 month
推荐新闻
-
发布时间 | 2026-05-18 11:08:55
N-十二烷基咪唑,1-dodeclimidazole,4303-67-7
-
发布时间 | 2026-05-18 11:08:54
甲氧基聚乙二醇葡萄糖酸 mPEG-Gluconic
-
发布时间 | 2026-05-18 11:08:09
1-烯丙基-3-乙烯基咪唑溴盐,1-Allyl-3-vinylimidazolium bromide,1072788-73-8
-
发布时间 | 2026-05-18 11:07:36
四甲基胍硫酸氢盐,tetramethylguanidine hydrogensulfate,25807-40-3
-
发布时间 | 2026-05-18 11:06:56
甲氧基聚乙二醇异硫氰酸酯 mPEG-ITC